PSU Profiles
Loading...
Keywords
Last Name
Institution

Yixing Jiang

TitleAssistant Professor
InstitutionCollege of Medicine
DepartmentMedicine
Address500 University Drive Hershey PA 17033
Phone7175318676
vCardDownload vCard

    Collapse Overview 
    Collapse overview
    PREFERRED TITLE/ROLE:

    Physician, Associate Professor of Medicine

    EDUCATION:

    Fellowship, Medical Oncology, M.D. Anderson Cancer Center
    Residency, Medicine, The Bronx Veteran's Affairs Medical Center
    M.D., Medical Center of Fudan University




    Collapse Bibliographic 
    Collapse selected publications
    Publications listed below are automatically derived from MEDLINE/PubMed and other sources, which might result in incorrect or missing publications. Faculty can login to make corrections and additions.
    List All   |   Timeline
    1. Tang X, Loc WS, Dong C, Matters GL, Butler PJ, Kester M, Meyers C, Jiang Y, Adair JH. The use of nanoparticulates to treat breast cancer. Nanomedicine (Lond). 2017 Oct; 12(19):2367-2388. PMID: 28868970.
      View in: PubMed
    2. Lim B, Jiang Y. Current and Emerging Systemic Therapy in Gastro-Esophageal Cancer "The Old and New Therapy for Metastatic Disease, The Role of Adjuvant and Neoadjuvant Therapy for Localized Disease". Curr Clin Pharmacol. 2015; 10(4):267-78. PMID: 26548904.
      View in: PubMed
    3. Jiang Y, Ajani JA. Anal margin cancer: current situation and ongoing trials. Curr Opin Oncol. 2012 Jul; 24(4):448-53. PMID: 22581355.
      View in: PubMed
    4. Joshi M, Jiang Y, Belani CP. Maintenance therapy for advanced non-small-cell lung cancer: switch versus continuation. Expert Opin Pharmacother. 2012 Apr; 13(5):685-97. PMID: 22404744.
      View in: PubMed
    5. Jiang Y, DiVittore NA, Kaiser JM, Shanmugavelandy SS, Fritz JL, Heakal Y, Tagaram HR, Cheng H, Cabot MC, Staveley-O'Carroll KF, Tran MA, Fox TE, Barth BM, Kester M. Combinatorial therapies improve the therapeutic efficacy of nanoliposomal ceramide for pancreatic cancer. Cancer Biol Ther. 2011 Oct 01; 12(7):574-85. PMID: 21795855; PMCID: PMC3218384.
    6. You H, Ding W, Dang H, Jiang Y, Rountree CB. c-Met represents a potential therapeutic target for personalized treatment in hepatocellular carcinoma. Hepatology. 2011 Sep 02; 54(3):879-89. PMID: 21618573; PMCID: PMC3181384.
    7. Kaifi JT, Gusani NJ, Jiang Y, Mackley HB, Dye CE, Mathew A, Kimchi ET, Reed MF, Staveley-O'Carroll KF. Multidisciplinary management of early and locally advanced esophageal cancer. J Clin Gastroenterol. 2011 May-Jun; 45(5):391-9. PMID: 21301357.
      View in: PubMed
    8. Rizvi S, Fateh S, Abbi KK, Jiang Y. Leptomeningeal carcinomatosis as the only manifestation of disease in recurrent gastroesophageal cancers. Gastrointest Cancer Res. 2011 Mar; 4(2):68-71. PMID: 21673879; PMCID: PMC3109883.
    9. Jiang Y, Ajani JA. Multidisciplinary management of gastric cancer. Curr Opin Gastroenterol. 2010 Nov; 26(6):640-6. PMID: 20827183.
      View in: PubMed
    10. Deshaies I, Cherenfant J, Gusani NJ, Jiang Y, Harvey HA, Kimchi ET, Kaifi JT, Staveley-O'Carroll KF. Gastrointestinal stromal tumor (GIST) recurrence following surgery: review of the clinical utility of imatinib treatment. Ther Clin Risk Manag. 2010 Oct 05; 6:453-8. PMID: 20957137; PMCID: PMC2952484.
    11. Jiang Y, Mackley H, Cheng H, Ajani JA. Use of K-Ras as a predictive biomarker for selecting anti-EGF receptor/pathway treatment. Biomark Med. 2010 Aug; 4(4):535-41. PMID: 20701442.
      View in: PubMed
    12. Jiang Y, Owonikoko TK, Ramalingam SS, Khuri FR, Belani CP. What is the role of maintenance therapy in the treatment of non-small cell lung cancer? Ther Adv Med Oncol. 2010 Jul; 2(4):229-35. PMID: 21789136; PMCID: PMC3126019.
    13. Jiang Y, Mackley H, Cheng H, Ajani JA. Anal carcinoma therapy: can we improve on 5-fluorouracil/mitomycin/radiotherapy? J Natl Compr Canc Netw. 2010 Jan; 8(1):135-44. PMID: 20064295.
      View in: PubMed
    14. Gusani NJ, Schubart JR, Wise J, Farace E, Green MJ, Jiang Y, Kimchi ET, Staveley-O'Carroll KF. Cancer survivorship: a new challenge for surgical and medical oncologists. J Gen Intern Med. 2009 Nov; 24 Suppl 2:S456-8. PMID: 19838850; PMCID: PMC2763148.
    15. Jiang Y. Advanced gastric cancer: a disease of diverse clinical biology. Gastrointest Cancer Res. 2009 May; 3(3):125-6. PMID: 19626158; PMCID: PMC2713139.
    16. Jiang Y, Kimchi E, Ajani JA. Localized squamous cell carcinoma of the esophagus: bimodality or trimodality approach? Future Oncol. 2009 Mar; 5(2):157-61. PMID: 19284374.
      View in: PubMed
    17. Huang J, Ren T, Guan H, Jiang Y, Cheng H. HTLV-1 Tax is a critical lipid raft modulator that hijacks IkappaB kinases to the microdomains for persistent activation of NF-kappaB. J Biol Chem. 2009 Mar 06; 284(10):6208-17. PMID: 19129196.
      View in: PubMed
    18. Gusani NJ, Jiang Y, Kimchi ET, Staveley-O'Carroll KF, Cheng H, Ajani JA. New pharmacological developments in the treatment of hepatocellular cancer. Drugs. 2009; 69(18):2533-40. PMID: 19943706.
      View in: PubMed
    19. Nikfarjam M, Shereef S, Kimchi ET, Gusani NJ, Jiang Y, Avella DM, Mahraj RP, Staveley-O'Carroll KF. Survival outcomes of patients with colorectal liver metastases following hepatic resection or ablation in the era of effective chemotherapy. Ann Surg Oncol. 2009 Jul; 16(7):1860-7. PMID: 19037703.
      View in: PubMed
    20. Jiang Y, Ming L, Montero AJ, Kimchi E, Nikfarjam M, Staveley-O'Carroll KF. Optimizing imatinib mesylate treatment in gastrointestinal stromal tumors. Gastrointest Cancer Res. 2008 Sep; 2(5):245-50. PMID: 19259308; PMCID: PMC2632557.
    21. Nikfarjam M, Kimchi E, Shereef S, Gusani NJ, Jiang Y, Liang J, Sehmbey M, Staveley-O'Carroll KF. Surgical outcomes of patients with gastrointestinal stromal tumors in the era of targeted drug therapy. J Gastrointest Surg. 2008 Nov; 12(11):2023-31. PMID: 18546049.
      View in: PubMed
    22. Jiang Y, Kimchi ET, Montero AJ, Staveley-O'Carroll KF, Ajani JA. Upper gastrointestinal tumors: current status and future perspectives. Expert Rev Anticancer Ther. 2008 Jun; 8(6):975-91. PMID: 18533807.
      View in: PubMed
    23. Yan G, Huang J, Jarbadan NR, Jiang Y, Cheng H. Sequestration of NF-kappaB signaling complexes in lipid rafts contributes to repression of NF-kappaB in T lymphocytes under hyperthermia stress. J Biol Chem. 2008 May 02; 283(18):12489-500. PMID: 18316375.
      View in: PubMed
    24. Jiang Y, Montero AJ, Staveley-O'Carroll KF. Adjuvant and preoperative therapy for localized gastric cancer. Gastrointest Cancer Res. 2007 Jul; 1(4):139-45. PMID: 19262702; PMCID: PMC2632522.
    25. Jiang Y, Cheng H. Evidence of LAT as a dual substrate for Lck and Syk in T lymphocytes. Leuk Res. 2007 Apr; 31(4):541-5. PMID: 16938345.
      View in: PubMed
    Jiang's Networks
    Click the "See All" links for more information and interactive visualizations!
    Concepts Expand Description
    _
    Co-Authors Expand Description
    _
    Similar People Expand Description
    _
    Same Department Expand Description
    Physical Neighbors Expand Description
    _